Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.
Rarity Bioscience has raised $536K in total funding. The most recent round was Seed. The last funding was announced in February 2023.
Rarity Bioscience's investors include Novalis Biotechnology Incubation, Navigare Ventures.
Rarity Bioscience is headquartered in Uppsala, Sweden.
Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.
Rarity Bioscience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rarity Bioscience — Funding & Investors." VCBacked, February 6, 2023, https://www.vcbacked.co/company/rarity-bioscience. Accessed September 30, 2026.
VCBacked. (2023). Rarity Bioscience — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/rarity-bioscience
{{cite web |title=Rarity Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/rarity-bioscience |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated